On the other hand, FABP-4 levels were influenced neither by HIV infection nor by ART-regimens but were associated with body composition, lipid profile, MetS score and estimated CVD risk (as previously reported both in subjects with and without HIV infection) [22, 24, 26]. This evidence concerns the gene FABP4 and metabolic syndrome.